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Abstract
The conceptual differentiation of spinal and neurogenic shock tends to be 
misunderstood among clinicians. In order to better illustrate the differences in 
definition, presentation, and development of spinal shock (SS) from neurogenic 
and other forms of shock, we present herein a clinically relevant summary of 
typical characteristics of SS. First described in the eighteenth century, the contin-
ued investigation into the disease process and the response of neural structures to 
spinal cord trauma have led to a more complete description and understanding. We 
will begin in the first part of the chapter describing the etiology of SS, including 
a working definition, as it pertains to complete spinal cord injuries (SCIs). This is 
followed by the summary of pathophysiology and clinical presentations associated 
with each clinical phase of SS. Finally, we explore treatment options and consid-
erations as they relate to incomplete SCI. We hope that by presenting a clear and 
well-delineated overview of SS, we will allow the clinician to better understand and 
more accurately predict the evolution of this process. This, in turn, should facilitate 
the ability to deliver better care for the patient.
Keywords: areflexia, clinical management, hyperreflexia, spinal injury, spinal shock, 
shock, trauma
1. Introduction and epidemiology
The specific definition of spinal shock (SS) has evolved over the past two 
centuries. Nonetheless, a significant level of ambiguity, controversy, and confusion 
still exists when differentiating between neurogenic shock (NS) and SS. Whytt 
first described this clinical entity in the 1750s without using the term “shock” 
and without the understanding of the underlying basic science and anatomy to 
accurately inform the definition. Rather, he focused on the observation that SS 
was associated with a loss of sensation accompanied by motor paralysis with initial 
loss but gradual recovery of reflexes [1]. The definition was then expanded over 
by Hall in the early 1840s, officially utilizing the terms “spinal shock” and “reflex 
arc” [2]. Another contributing factor to the previously elusive definition is the lack 
of uniform clinical presentation, manifestation, and duration of SS. Due to the 
substantial clinical variability and heterogeneity of presentations, we must first 
discuss the definitional aspect of SS so that the reader may have a clear idea and a 
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working model for our subsequent discussions of diagnosis, patient presentation, 
and treatment approaches.
Ditunno made a subtle point that the controversy surrounding the definition of 
SS could be attributed to observations made clinically. More specifically, he noted 
that not all reflexes are eradicated in a strictly binary on/off fashion. Some reflexes 
may only be depressed and yet still can be technically elicited. Finally, he noted that 
the resolution of SS does not occur in a binary fashion and often follows a prolonged 
course of weeks to months [3]. Similar observations by Illis suggested that the defi-
nition of SS cannot be comprehensive without including subcomponent definitions 
of clinical phases [4]. For the purposes of this chapter, we will utilize Ditunno’s 
four-phase model of spinal shock, building upon the groundwork described by 
various pioneers such as Whytt and Hall [1, 3]. This model allows for clarification 
of the ambiguity surrounding the disease process while still retaining flexibility 
to appreciate the variability among clinical presentations. The details of Ditunno’s 
four-phase model can be seen in Table 1 [3].
The phases are organized according to post-injury time and the nervous system’s 
response to insult. Of note, we will hold off on the discussion of each phase until 
the Etiology and Pathophysiology section as the separation of phases requires delving 
into how the neurons are responding to their environment as time progresses.
In 2007, there was an estimated global spinal cord injury (SCI) incidence of 2.3 
cases/100,000 inhabitants [5]. It has been estimated 45% of SS cases are associ-
ated with motor vehicle collisions (MVC), 34% with domestic accidents, 15% 
with sporting accidents, and 6% with self-harm [6]. The incidence of SCI can vary 
across geographic, socioeconomic, and cultural factors, including the prevalence of 
contact sports and differences in primary transportation modality. All of the above 
factors are important determinants of the incidence of SCI. Finally, no discussion 
of the topic of SCI is complete without mentioning the tremendous human and 
economic cost associated with these injuries worldwide [7–9].
2. Spinal shock: etiology and pathophysiology
Spinal cord injuries (SCI) are typically divided into two subtypes, complete and 
incomplete. An SCI is considered incomplete if there is some degree of residual 
motor and/or sensory function below the neurologic level of injury that includes the 
lowest sacral segments, where the neurologic level of injury is defined as the most 
caudal level at which both motor and sensory modalities remain preserved [10]. It 
follows that patients affected by a complete SCI will not retain sensory or motor 
function in the lowest sacral segments.
Phase Timing Neurological changes
1 0–1 day 1. Decreased spinal and supraspinal excitation
2. Loss of 5-HT production leading to loss of plateau potentials
3. Reduction of available synapses and dendrites
2 1–3 days 1. Increased postsynaptic sensitivity
2. Receptor upregulation due to decreased neurotransmitter activity
3 1–4 weeks 1. Increased neurotrophin activity allows for increased synaptic growth
2. Increased interneuron growth
3. Plateau potentials recovered in spinal neurons
4 1–12 months 1. Synapse growth in long axons
Table 1. 
Four phases of spinal shock by Ditunno et al.
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Before directing our discussion to the management in incomplete SCI, additional 
information will be provided regarding complete SCIs, specifically in the context 
of SS. The understanding of key processes surrounding complete SCI is conceptu-
ally easier, especially when compared to the understanding of incomplete SCI. It 
is important to note that although severed neurons are separated from descend-
ing input—both excitatory and inhibitory—there remains synaptic contact with 
associated interneurons and reflex afferents, and even new synaptic connections 
can be established with sprouting neurons [11, 12]. Our subsequent discussion will 
describe the previously outlined “four phases” of spinal shock.
2.1 Phase I
As outlined in Table 1, Phase I of SS is marked by areflexia/hyporeflexia, a con-
sequence of the loss of descending mediation. This phase occurs from 0 to 24 hours 
from time of injury. Under normal circumstances, both spinal motor neurons and 
interneurons receive certain baseline levels of background excitatory input from 
supraspinal axons. When an individual wishes to initiate voluntary movement, 
additional stimulus is superimposed above this “background activity.” Supraspinal 
inputs mediating the background excitation of spinal motor neurons and interneu-
rons are numerous and include vestibulospinal and reticulospinal pathways [13]. 
These two pathways will now be discussed in more detail.
The vestibulospinal pathway arises from first-order neurons located in Scarpa’s 
ganglion which is situated in the distal part of the internal auditory meatus [14]. 
Afferents are sent from the ganglion through the vestibular part of the eighth 
cranial nerve before entering the brainstem at the pontomedullary junction. Upon 
entry, there are four second-order vestibular nuclei; however, we shall focus on the 
medial and lateral vestibulospinal tracts for the purposes of our current discus-
sion. The medial and lateral vestibulospinal tracts arise from the medial and lateral 
vestibular nuclei, respectively [15, 16]. The latter descends the entire length of the 
spinal cord ipsilaterally and plays a crucial role in walking upright, while the former 
descends bilaterally in the medial longitudinal fasciculus and terminates at the mid-
thoracic level, facilitating the integration of head and eye movements [17, 18].
The reticulospinal pathway arises from the brainstem, the pontine reticular 
formation, and the medullary reticular formation [19, 20]. Pontine reticular fibers 
traveling in the pontine reticulospinal tract remain uncrossed as they descend in 
the medial longitudinal fasciculus, terminating in axial and limb muscles involved 
in posture and gait stability [21]. At the level of the muscle, their effects are at least 
threefold: (a) facilitation of movement, (b) regulation of reflexes, and (c) contri-
bution to muscle tone. The medullary reticular fibers traveling in the medullary 
reticulospinal tract serve a slightly different role [22–24]. First, the fibers origi-
nating from the medullary reticulospinal formation are located bilaterally in the 
reticulospinal tracts as they descend; however, most of the fibers remain uncrossed. 
As they terminate on axial and limb muscles, they serve an inhibitory role during 
the modulation of voluntary movement and reflexes.
In addition to supraspinal inputs, serotonergic (5-HT) neurons and noradrener-
gic (NE) neurons originating from the raphe nucleus and locus coeruleus, respec-
tively, may also play a role in the background excitatory input as they influence 
spinal cord motor systems [25]. Mechanistically, this may involve the production of 
plateau potentials [26, 27]. The plateau potentials originate on dendrites, believed 
to be mediated through sustained activation of Ca2+ channels, and provide ampli-
fication of excitatory inputs, with approximately sixfold “gain,” thus allowing for 
prolonged neuronal firing with minimal excitatory input, as well as contributing to 
the background basal excitatory stimulation [28–30].
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Baseline excitability in muscle spindles may also be handled in part by gamma-
motor neurons [31, 32]. Upon SCI, gamma-motor neurons caudal to the injury may 
lose their ability to influence motor neurons via stretch reflex afferents as they lose 
their tonic descending facilitation. The loss of descending inhibition of inhibitory 
pathways within the spinal cord must also be considered, primarily because it likely 
contributes to decreased spinal reflexes [33, 34].
Finally, some of the more delayed developments involving the injured cord, both 
metabolic and structural, could contribute to the observed areflexia/hyporeflexia 
characteristics of SS. At the same time, the observed areflexia/hyporeflexia usually 
occurs immediately post-SCI, making any other pathophysiologic considerations 
secondary—rather than primary—factors [35, 36]. This “secondary factor” list 
includes (a) dendritic retraction and synaptic degeneration seen within 1–3 days 
post-SCI; (b) impaired delivery of metabolites and secretion of neurotrophins; and 
(c) the impact of growth factors caudal to the neurologic level of injury [36–38].
Upon traumatic injury resulting in complete SCI, the baseline excitation from 
supraspinal inputs will be lost, leading to hyperpolarization of the neurons [39]. 
This hyperpolarization leads to the neurons becoming less excitable and yields the 
clinical picture in Phase I.
2.2 Phase II
Appearing 1–3 days following the SCI, the return of cutaneous reflexes is 
observed [3]. It is still unknown whether this is due to replacement of synapses or 
to denervation supersensitivity. Morphological changes in the synapses have been 
documented within hours to days of SCI; however, these synapses may not become 
functional until weeks—or even months—have passed, making this an unlikely 
contributor to Phase II developments [40–45].
Denervation supersensitivity is defined as increased neuronal firing in response 
to a neurotransmitter [46]. This phenomenon has been shown to occur in both the 
peripheral (PNS) and central (CNS) nervous systems, including the brain and the 
spinal cord [47–51]. The proposed mechanisms involves upregulation of mRNA 
transcription and protein translation that begins within hours and peaks within 
days post-SCI, which is within the time scale of empirically observed changes [52]. 
More specifically, the overall process leads to increased synthesis and insertion of 
receptors into the postsynaptic membrane, altered synthesis and assembly of recep-
tor subunits, decreased removal and/or degradation of receptor(s), and reduced 
excitatory neurotransmitter reuptake [52–55]. Mechanistically, NMDA glutamate 
receptors, serotonin 2A, and vanilloid VR1 receptors have been shown to increase 
either in association with mRNA synthesis or the observed density at the synapse 
[54, 56–58]. Hypoactivity of neurons has been shown to constitute a sufficient 
stimulus to increase production of the NMDA glutamate receptors [55]. Although 
the exact details are yet to be elucidated, neurotrophins, growth factors, and their 
respective receptors have been shown to stimulate an increase in transcription 
and translation [59–64]. Postulated downstream effects involve the modulation 
of NMDA receptors, resulting in increased excitability and/or decreasing GABA 
synaptic inhibition [65]. These effects seem to play a role in the development of SS 
during the initial period of 1–3 days post-SCI [3].
2.3 Phases III and IV
Stages III (1–4 weeks) and IV (1–12 months) of SS are often linked together 
and are best described through the lens of the human tibial H-reflex. The H-reflex 
has been used to model the recovery of reflexes caudal to SCI over time [66, 67]. 
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In this context, an interesting phenomenon is observed beyond post-injury “day 
3” temporal marker. More specifically, there is an increased reflex excitability 
observed at 2–4 weeks post-SCI with an increase in latency and another increase in 
reflex excitability at approximately 3–4 months post-SCI [3].
Overall, it has been shown that the 2–4-week mark increase in excitability can 
be attributed to axon-supplied synapse growth and/or disynaptic interneurons, 
while the increase in excitability at 3–4 months is mediated by primary afferents 
and/or soma-supplied synapse growth [3]. The timing of the observed changes in 
excitability suggests that there is an axon-length-dependent rate of synapse growth. 
Two mechanisms have been proposed to explain this phenomenon: (a) two periods 
of synaptic growth—early findings dependent on axonal synthesis and the later 
growth period dependent on somal synthesis and (b) disynaptic stretch reflex 
pathways, such as the Golgi tendon organ reflex, are preferentially hyperexcitable 
relative to the monosynaptic Ia afferents to motoneurons [3].
3. Diagnosis and clinical presentation
3.1 Phase I
Caudal to complete SCI within the first 24 hours, Phase I will present with flaccid, 
paralyzed muscles and deep tendon reflexes (DTRs) being initially absent. While the 
DTRs such as the ankle jerk (AJ) and knee jerk (KJ) are absent, a pathologic reflex, 
delayed plantar response (DPR), is often the first to return and should be observed 
within hours post-SCI [68]. Other cutaneous and polysynaptic reflexes such as the bul-
bocavernosus (BC), cremasteric (CM), and anal wink (AW) can also be seen to return 
during Phase I. Location of the lesion can be determined based on presenting symp-
toms. Lesions above the mid-pons will cause decerebrate rigidity, while those located 
below the mid-pons cause hyporeflexia [69]. In addition to skeletal motor and reflex 
findings during this time, there are autonomic findings that may be relevant if the 
lesion is in the cervical area. Findings include hypotension, atrioventricular conduction 
block, and bradyarrhythmia, and these can be continued through Phases II and III [3]. 
These findings are consistent with neurogenic shock, detailed in a separate chapter.
3.2 Phase II
One to 3 days post-SCI, the clinician should expect to see continued reflex 
return. Building upon Phase I, the cutaneous reflexes, BC, AW, and CM, become 
stronger [3]. Except for two patient populations, namely, the elderly and children, 
DTRs are still absent; however, the tibial H-reflex returns around the 24-hour 
marker [70, 71]. In the elderly, DTRs and the Babinski sign can occur during this 
phase [68]. Although not known for certain, the presence of pre-existing subclini-
cal myelopathy might contribute to this early recovery as some animal studies have 
exhibited quicker recovery of DTRs in the setting of prior upper motor neuron 
lesions [68, 72, 73]. Children exhibit similar recovery, showing DTRs sometimes 
3 days post-SCI, which might be attributable to their still developing descending 
supraspinal tracts, predisposing them to spinal hyperreflexia. The recovery of 
cutaneous reflexes during phase II is likely due to receptor plasticity [3].
3.3 Phase III
The third phase (days 4–30) is marked by early hyperreflexia. Excluding the 
two patient populations discussed in Phase II, almost all patients will regain DTRs 
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during this period [3, 68]. The return of these reflexes is as follows: Babinski sign 
recovery will follow AJ recovery closely, with the AJ preceding the return of the KJ 
[3, 68, 74]. The clinician should expect to see most DTRs resolve during this phase 
with only 10% persisting beyond Phase III [3]. Ditunno discussed the variability of 
reflex return regarding the timing trend. There have been studies showing reduced 
tendon reflex excitability in certain trained populations, such as ballet dancers and 
power-trained athletes, relative to untrained or even endurance athletes [75–77]. 
There has also been evidence that pre-SCI experiences could influence the reflex 
excitability below an SCI [78, 79]. During this time the clinician will have to be 
aware of the developing autonomic functions. There is expected improvement in 
the bradyarrhythmia and hypotension described before; however, around this time 
autonomic dysreflexia can arise and is most commonly due to a distended blad-
der or bowel causing a massive sympathetic outflow below the neurologic level of 
injury [3]. Autonomic dysreflexia can lead to difficult-to-control hypertension and 
bradycardia and is most commonly seen in patients with SCI at or above T6 but has 
been seen as low as T10 [80].
3.4 Phase IV
One to 12 months post-injury, spasticity and hyperreflexia usually set in, charac-
teristic of Phase IV. The remaining DTRs not extinguished during Phase III of SS 
should become absent during this period [3]. Minimal stimuli will elicit cutaneous 
reflexes, Babinski sign, and DTRs. It has been estimated that there will be detrusor 
paralysis recovery by 4–6 weeks [3]. The autonomic dysreflexia described in Phase 
III can also develop during Phase IV, including malignant hypertension, and follow-
ing its emergence can become chronic/protracted.
4. Treatment
A detailed history is imperative for accurate diagnosis and treatment of spinal 
shock. As mentioned previously, prior patient life experiences (i.e., athletes, 
ballerinas, etc.) may play a role in the rate of hyperreflexia appearance [3]. Thus, a 
thorough history will help guide appropriate expectations of the clinical evolution 
of reflexes. The history will also help direct the clinician to what developments 
could be expected as these can depend on the type, severity, and timing of the 
incident. Certain substances and chemical mediators for reducing inflamma-
tory processes, protecting neurons, and regenerating neural capacities have been 
investigated for efficacy in the management of SCI [6, 81–88]. Corticosteroids, 
specifically methylprednisolone, have been postulated to be part of a generalized 
recommendation to help alleviate inflammatory processes mediated by neutrophils 
and macrophages; however, clinical trials and non-randomized studies point to not 
having this as a general recommendation [81–85]. It has been recommended that a 
young patient, free of any underlying disease which could be influenced by corti-
costeroids, could be started on a short trial of methylprednisolone with a loading 
dose of 30 mg/kg with a maintenance dose of 5/mg/kg/h for the next 24 hours [6]. 
Symptomatic medications for autonomic dysfunction can include treatments for 
headaches, flushing, elevated blood pressure, orthostasis, and bladder and abdomi-
nal distension. Prompt attention to bowel and bladder hygiene, bladder catheteriza-
tion, cautious use of bowel preparations, and anticholinergic medications may help 
with any associated hemodynamic instability. There are ongoing investigations 
into G-CSF and FGF-2, among others, as possessing neuroprotective qualities as 
well as stem cells of varying stages, olfactory ensheathing cells, and mesenchymal 
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stromal cells that are possible candidates for regenerating neural capacities [86–88]. 
Consequently, the clinician should remain up to date on the current literature for 
therapeutic developments. Providers should also keep in mind that lesions above T6 
can be accompanied by neurogenic shock, and we refer you to the neurogenic shock 
chapter for the diagnosis and management of that phenomenon.
Current guidelines and recommendation can be split up based on the loca-
tion of SCI.
Cervical SCI:
1. Immediate immobilization through traction and alignment.
2. Identify if injury is above c5.
a. Above C3: Immediate mechanical ventilation.
b. C3–C5: Monitor closely for respiratory decompensation and ventilate if 
necessary.
c. Maintain supportive care and ensure SBP > 90.
3. Neurosurgery consult to determine if neurosurgery is necessary [89].
Thoracolumbar SCI:
1. Stable fractures: Stabilization with brace from 6 to 12 weeks.
2. Unstable fractures: Surgical decompression [90].
Sacral SCI:
1. Unstable sacral fractures:
a. Identify any active bleeds.
b. Immediate reduction.
2. Stable sacral fracture:
a. Reduction with brace for up to 4 months.
b. Limit activity.
While it has been a standard practice to give high-dose methylprednisolone after 
spinal cord injury, recent studies have found that there is no advantage of steroids 
when considering neurological recovery [91, 92]. Given that SCI can result in long 
periods of immobility, it is important to consider antithrombotic prophylactic treat-
ment. If patient is on bed rest, gastric and skin ulcer precautions must also be in place.
5. Considerations for incomplete SCI
Incomplete SCI can be classified using the American Spinal Injury Association 
(ASIA) into three broad categories. Grade A, B, and C injury designations are based 
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on functions that are preserved. Table 2 describes the preserved functions in all 
grades. Incomplete spinal cord injuries can be categorized into four types: central 
cord syndrome, anterior cord syndrome, posterior cord syndrome, and Brown-
Sequard syndrome.
The incidence of incomplete SCI has reported range from 40 to 50% of all spinal 
injuries [93–95]. Central cord syndrome tends to be the most common injury with 
posterior cord being the rarest of the incomplete spinal injuries. We will start by 
exploring the central cord syndrome. Most cases of incomplete SCI are caused by 
motor vehicle accidents (MVA), falls, and swimming injuries [96, 97].
5.1 Central cord syndrome
Central cord syndrome (CCS) is seen primarily in patients in the fifth decade of 
life and beyond and is usually a result of hyperextension injury [95, 98]. In younger 
patients, CCS is usually due to high-velocity trauma. CCS in older patients tends to 
occur in the setting of pre-existing degenerative narrowing of the spinal canal; this 
narrowing combined with hyperextension can cause an expanding hematoma that 
exerts pressure on the spinal cord [99]. Depending on the location and severity, we 
see a different range of symptoms. Milder injuries can result in burning sensation 
of the upper extremities. Most presentations consist of weakness in all limbs, with 
upper extremities more affected than the lower extremities. Majority of central 
cord injuries are due to a lesion at the levels of C4–C6. Patients with the following 
history and signs should be evaluated for CCS [100].
1. Patients over 50 years of age: Hyperextension with a previous history of 
 degenerative changes in the spinal canal.
2. Patients under 40 years of age: High velocity trauma (MVA, skiing, etc.).
3. Sensory Loss: Cape-like distribution (upper extremities and thorax with 
 sacrum spared).
4. Motor loss: Weakness that is more prominent in the upper extremities than 
lower extremities.
5. Autonomic regulation: Loss of bowel and bladder. Orthostatic hypotension 
may also be seen [101].
Any patient that is being evaluated for incomplete SCI should have a high-
resolution computed tomography (CT) to identify spinal fractures, dislocations, 
Grade Description
A Complete spinal cord injury. No motor or sensory function
B Motor function is lost, while sensory function is preserved
C Sensory function is lost, with motor function spared at the sacral level
D Sensory functions intact, and all motor functions are at least grade 3/5 (able to move against 
gravity, but not against active resistance)
E No loss of function noted
Table 2. 
American Spinal Injury Association (ASIA) classification for incomplete spinal cord injuries at level of injury.
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and potential hematomas [100]. A magnetic resonance imaging (MRI) should 
be considered when CT is normal, but CCS is still suspected. In roughly 4–6% of 
individuals with CCS, it is possible that all imaging, with the exception of MRI, can 
show no abnormalities. Once the severity on the CCS is identified and classified 
using the American Spinal Injury Association (ASIA) scale (Table 2), management 
pathway can be selected [102]. The Congress of Neurological Surgeons recommends 
that patients receive immediate surgery in cases of fractures or dislocations [103, 104]. 
However, decompressive surgery in CCS is controversial as many studies looking at 
outcomes comparing surgical and nonsurgical management have been inconclusive. 
The use of steroids is not recommended as it has been shown no benefit when com-
pared to observation [105–109].
It has been noted that 75–80% of patients can regain full neurological recovery 
[96, 110, 111]. Depending on the ASIA score that was determined during admis-
sion, one can begin determining prognostic considerations [112]. Usually younger 
patients with CCS from traumatic injuries tend to have the best prognosis [113]. The 
timeline for recovery can be up to 1 year after injury. Patients will usually regain 
functions in an ascending manner [99].
5.2 Brown-Sequard syndrome
Unlike CCS, the Brown-Sequard syndrome (BSS) is a rare type of incomplete 
SCI [114]. It is usually seen in penetrating trauma, including knife and gunshot 
wounds. It can also occur with the loss of vascular supply due to a herniation or 
edema to a hemisection [115–117]. BSS presents with ipsilateral loss of motor 
function, ipsilateral loss of sensation, and proprioception and contralateral loss 
of pain and temperature [114]. These symptoms are due to a lesion involving the 
corticospinal, dorsal column, and spinothalamic tracts, respectively. In some cases, 
there is loss of bowel and bladder function. BSS has the best prognosis of all the 
incomplete spinal cord injuries. Roughly 90–99% of patients gain back full function 
[99]. Diagnosis should be suspected based on a combination of physical examina-
tion/presenting signs and confirmed with an MRI. Management is similar to CCS, 
consisting of conservative approach with a strong focus on early rehabilitation. 
Surgery is indicated in the following scenarios [118–121]:
1. Lesion requiring decompression.
2. Presence of a tumor.
3. An abscess compressing the spinal cord.
Complete recovery following BSS can take up to 2 years. However, most patients 
regain full motor skills within the first 6 months. Pain and temperature sensations 
tend to recover before full motor function is regained [122, 123]. It is vital that 
patients receive immediate physical therapy following the acute treatment phase to 
maximize recovery. During the treatment and management phase of BSS, providers 
must be careful in completely addressing the underlying condition that lead to BSS, 
such as spinal cord herniation or a CSF leak through a dural tear, as these could lead 
to permanent loss of neurologic function [124, 125].
5.3 Anterior cord syndrome
Anterior cord syndrome (ACS) is a rare incomplete SCI that accounts for 
approximately 1–3% of spinal injuries [95]. It also has the worst prognosis of all the 
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incomplete SCI, with only 10–20% of patients achieving some level of functional 
recovery [126]. ACS has two primary pathogenetic mechanisms. In about 90% 
of cases, it is caused by decreased vascular perfusion to the anterior spinal artery 
which supplies the anterior 2/3 of the spinal cord [95, 126]. Another possible 
cause is from increased direct pressure on the spinal cord caused by compression 
trauma or “over-flexion” [127]. The first signs of ACS include bilateral loss of motor 
function, pain, and temperature sensation. These findings are more dominant in 
the lower extremities. Patients also tend to present with loss of bladder and bowel 
function [126]. Presentation of ACS is usually acute with severe back pain and 
loss of neurologic function mentioned. The best confirmatory test is a spinal MRI; 
however, computed tomography angiography (CTA) may be used for faster diagno-
sis. Emergent surgical management may be required depending on the underlying 
pathology responsible for the ACS (e.g., aortic aneurysm). Once the underlying 
condition is treated, management of ACS is similar to other SCIs and consists of 
physical and occupational therapy. While the patient may never regain the lost 
motor and sensory function, it is vital that physical therapy is provided on a regular 
basis to prevent contractions and spastic paralysis [128].
5.4 Posterior cord syndrome
Posterior cord syndrome (PCS) has an incidence of roughly <1% [95, 99]. Like 
ACS it carries a very poor prognosis. The causes of PCS include vascular compro-
mise to the posterior spinal artery, trauma, multiple sclerosis (MS), vitamin B12 
deficiency, and syphilis. Since PCS affects the posterior aspect of the spinal cord 
containing dorsal column fibers, one typically sees presentations that involve loss 
of proprioception and vibratory sensation with motor function being preserved. 
Patients occasionally will have sensation of “electric shocks” running down their 
spine, which is known as Lhermitte’s sign and can indicate MS or a metabolic 
deficiency [121, 128]. CTA might allow for rapid diagnosis of vascular comprise/
threat and allow for emergent treatment. However, MRI imaging showing infarc-
tions is the most reliable method of confirming the diagnosis [99]. Once the 
underlying pathology is treated, PCS management will require rigorous physical 
and occupational rehabilitation course [121].
6. Conclusions
It is important to distinguish the differences between spinal shock and neu-
rogenic shock, both in terms of definitions and clinical manifestations. Spinal 
shock encompasses a diverse set of injuries involving various parts of the spinal 
Spinal shock Neurogenic shock




Possible, depending on the location and 
severity of injury
Always
Onset time Sudden to days Sudden
Time to resolution Weeks to months Hours to days
Table 3. 
Spinal shock versus neurogenic shock.
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cord, whereas neurogenic shock tends to be a result of spinal injuries above the 
level of T6. Spinal shock occurs in phases (I–IV) that are temporally distributed 
over a period of weeks to months, whereas neurogenic shock tends to have sudden 
onset that requires more urgent management. Table 3 outlines the key differences 
between spinal and neurogenic shock. Patients with SS and injuries above the 
level of T6 should always be evaluated for neurogenic shock symptoms, such as 
Figure 1. 
This represents the different tracts on a T8 spinal cross section. The sensory pathways (S) and motor pathways 
(M) are identified with specific characteristics depicted on the right. This image was created using Biorender 
and is used here based on the terms and conditions of Biorender®.
Figure 2. 
Image representing lesion that would be considered Brown-Sequard and the pathways involved in the 
hemisection injury. This image was created using Biorender and is used here based on the terms and conditions 
of Biorender®.
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Figure 3. 
Image represents central cord injury and the pathways involved. This image was created using Biorender and is 
used here based on the terms and conditions of Biorender®.
Figure 4. 
Image represents anterior cord injury and the pathways involved. This image was created using Biorender and 
is used here based on the terms and conditions of Biorender®.
hypotension, hypothermia, and bradycardia. Both complete and incomplete SS 
injuries can develop hypotension but will not develop systemic vasodilation (as 
would be seen in the event of neurogenic shock). Accurately differentiating neu-
rogenic and spinal shock is important because it will help clinicians in determining 
important management decisions in patients with SCI (Figures 1–5).
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SCI spinal cord injury
DTR deep tendon reflex






CCS central cord syndrome
BSS Brown-Sequard syndrome
ACS anterior cord syndrome
PCS posterior cord syndrome
CSF cerebrospinal fluid
Figure 5. 
Image represents posterior cord injury and the pathways involved. This image was created using Biorender and 
is used here based on the terms and conditions of Biorender®.
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